10-K Decoder · All companies

Pulse Biosciences, Inc.

PLSE · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$350K$0K
Operating income−$76.9M−$56.3M−36.8%
Net income−$72.8M−$53.6M−35.8%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$400K$100K+300%
Operating income−$24.3M−$20.4M−19.1%
Net income−$23.1M−$19.4M−19.1%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Pulse Biosciences's revenue in FY2025?
$350K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Feb 2026.
Was Pulse Biosciences profitable in FY2025?
No: net income was −$72.8M and operating income −$76.9M in FY2025.
What was Pulse Biosciences's revenue in Q3 2026?
$400K (+300% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.